The newer cholesterol-lowering medications, PCSK9 inhibitors, have been shown to lower Lp(a) levels.[ref] A 2026 placebo-controlled clinical trial using the PCSK9 inhibitor enlicitide also showed a decreased in Lp(a) levels at 24 weeks.[ref] Aspirin: A study of over 12,000 people over age 70 looked at the effect of 100mg of aspirin daily
Meessen ECE, Warmbrunn M V, Nieuwdorp M, Soeters MR
In fact, it can be deceiving because muscle weighs more than fat
Advise patients to seek urgent medical attention if these occur
it reflects pharmacokinetics only., Weigh the indication: More conservative avoidance is typically used for elective weight loss, while diabetes management may require individualized planning with obstetric care. Estimated washout timelines (drug clearance, not infant safety) Bottom line breastfeeding and GLP-1 medications While no evidence proves harm, many clinicians currently recommend avoiding GLP-1 medications for weight loss during breastfeeding